Add Yahoo as a preferred source to see more of our stories on Google. Samsung Biologics will conduct a simulated outbreak response using wild-type H5 influenza as a prototype pathogen The Coalition ...

Matthew Downham, CEPI’s director of manufacturing and supply chain networks, tells GEN, “Through this partnership, CEPI and Samsung Biologics will establish a pre-agreed, ready-to-activate ...

The Coalition for Epidemic Preparedness Innovations (CEPI) is dishing out up to $2.5 million to Codiak BioSciences to develop vaccines for COVID-19 and the mystery disease X that could strike next.

OSLO, Norway and INCHEON, South Korea, Feb. 3, 2026 /PRNewswire/ -- The Coalition for Epidemic Preparedness Innovations (CEPI) and Samsung Biologics (KRX: 207940.KS), a leading contract development ...

RESEARCH TRIANGLE PARK, N.C. & OSLO, Norway--(BUSINESS WIRE)--IQVIA, (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services, and The ...

With $1.1 billion already secured and committed, the organisation is seeking further investments from governments, ...

OSLO, Norway, Nov. 20, 2025 /PRNewswire/ -- Cognizant (Nasdaq: CTSH), a leading global professional services company, today announced that it has been selected by the Coalition for Epidemic ...

York College Community Vaccination Center personnel receive a shipment of Pfizer vaccines April 12, 2021, and place them in cold storage until they are administered to local residents. (K.C.

If licensed and in the event of an influenza pandemic, Moderna will allocate 20% of its H5 pandemic vaccine manufacturing capacity for timely supply to low- and middle-income countries at affordable ...

OSLO, Norway and CAMBRIDGE, Mass., July 05, 2022 (GLOBE NEWSWIRE) -- CEPI, the Coalition for Epidemic Preparedness Innovations, and Codiak BioSciences (NASDAQ: CDAK) today announced the latest funding ...